The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Guerrero Ramiro since 2022.
This trader's CIK number is 1913253.
At the time of last reporting, Guerrero Ramiro was the Director of Maia Biotechnology, Inc.. (stock ticker symbol MAIA).
Also see all insider trading activities at Maia Biotechnology, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | MAIA | 126,666 | $189,998 | 0 | $0 | 0 | $0 |
2024 | MAIA | 148,880 | $330,323 | 0 | $0 | 0 | $0 |
2023 | MAIA | 15,208 | $44,170 | 0 | $0 | 0 | $0 |
2022 | MAIA | 38,081 | $170,995 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-08 | MAIA | Buy | 20,000 | 1.50 | 30,000 |
2025-03-03 | MAIA | Buy | 33,333 | 1.50 | 49,999 |
2025-02-24 | MAIA | Buy | 73,333 | 1.50 | 109,999 |
2024-12-13 | MAIA | Buy | 53,418 | 1.87 | 99,998 |
2024-11-01 | MAIA | Buy | 88,534 | 2.51 | 222,220 |
2024-03-14 | MAIA | Buy | 6,928 | 1.17 | 8,105 |
2023-05-18 | MAIA | Buy | 1,200 | 2.47 | 2,964 |
2023-04-27 | MAIA | Buy | 8,500 | 2.25 | 19,125 |
2023-04-18 | MAIA | Buy | 1,263 | 4.17 | 5,266 |
2023-03-16 | MAIA | Buy | 1,333 | 3.64 | 4,852 |
2023-03-09 | MAIA | Buy | 1,057 | 3.98 | 4,206 |
2023-03-10 | MAIA | Buy | 443 | 3.98 | 1,763 |
2023-03-06 | MAIA | Buy | 481 | 4.24 | 2,039 |
2023-03-07 | MAIA | Buy | 871 | 4.25 | 3,701 |
2023-02-17 | MAIA | Buy | 50 | 4.25 | 212 |
2023-02-16 | MAIA | Buy | 10 | 4.25 | 42 |
2022-09-13 | MAIA | Buy | 8,798 | 3.85 | 33,872 |
2022-08-30 | MAIA | Buy | 283 | 3.97 | 1,123 |
2022-07-28 | MAIA | Buy | 9,000 | 4.00 | 36,000 |
2022-08-01 | MAIA | Buy | 20,000 | 5.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Guerrero Ramiro (Director of Maia Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.